BiondVax Pharmaceuticals Ltd. | October 2020

Partners Dr. Ayal Shenhav, Perry Wildes, Oded Bejarano, and Attys. Joshua Ravitz, Moshe Abrumovsky and intern Tamar Shamir represented client BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering (ATM) of American Depositary Shares for up to a maximum offering price of $100 million.

See link for additional information.